TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Pelvic exenteration for recurrent gynaecological cancer after radiotherapy

Key Statistics

  • <2% — Operative mortality (modern series)
  • 14% — Reported max operative mortality
  • 50–54% — 5-Year survival, R0 resection

Don't-miss facts

  1. Curative intent requires R0 resection + no metastatic disease outside the operative field – determined largely intra/postoperatively

  2. Diagnostic laparoscopy is routine: up to 16% of PET-CT-negative women have peritoneal disease found at laparoscopy

  3. Sciatic nerve involvement and peritoneal metastases are absolute contraindications to exenteration

  4. Operative mortality quoted at <2% for counselling (reported range up to 14%); serious morbidity rate 50%; return-to- theatre up to 48%

  5. Time to recurrence drives survival: <2y → 16.8%, 2–5y → 28%, >5y → 83.2% 5-year survival

  6. R0 vs involved margin 2-year survival: 55.2% vs 10.2%

  7. Empty pelvic syndrome = bowel herniation/fistula into unreconstructed translevator pelvic floor – potentially fatal; VRAM/ORAM flap preferred over synthetic mesh

  8. LEER (Höckel) and Cyberknife® are options for pelvic sidewall recurrence, historically considered inoperable

Exenteration types (magrina)

Type I – supralevator: levator & vulva intact Type II – infralevator: limited levator resection

Type III – infralevator + vulvectomy: complete levator & vulval resection

Abbreviation Key

  • R0/R1/R2 — complete / microscopic / gross residual disease at
  • VRAM — vertical rectus abdominis myocutaneous (flap) resection margin
  • ORAM — oblique rectus abdominis myocutaneous (flap)
  • RT — radiotherapy
  • ADM — acellular dermal matrix
  • QoL — quality of life
  • TPN — total parenteral nutrition
  • EUA — examination under anaesthesia
  • HDU/ITU — high dependency unit / intensive therapy unit
  • PET-CT — positron emission tomography–computed tomography
  • LEER — laterally extended endopelvic resection
  • MRI — magnetic resonance imaging
  • LMWH — low molecular weight heparin (anticoagulation)
  • BMI — body mass index

Source: Kolomainen DF, Barton DPJ. Pelvic exenteration for recurrent gynaecological cancer after radiotherapy. The Obstetrician & Gynaecologist 2017;19:109–118. doi:10.1111/tog.12383

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free